Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-001150
Filing Date
2019-01-14
Accepted
2019-01-14 19:50:09
Documents
2
Period of Report
2019-01-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3930
2 EX-24 DOCUMENT attachment1.htm EX-24 3033
  Complete submission text file 0000899243-19-001150.txt   8481
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Issuer) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INFINERA CORPORATION 140 CASPIAN COURT SUNNYVALE CA 94089
Business Address
Welch David F (Reporting) CIK: 0001399122 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-49908 | Film No.: 19526009